491 related articles for article (PubMed ID: 26230755)
1. (90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.
Camacho JC; Moncayo V; Kokabi N; Reavey HE; Galt JR; Yamada K; Kies DD; Williams RS; Kim HS; Schuster DM
Radiographics; 2015; 35(5):1602-18. PubMed ID: 26230755
[TBL] [Abstract][Full Text] [Related]
2. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
3. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
[TBL] [Abstract][Full Text] [Related]
4. Outpatient single-session yttrium-90 glass microsphere radioembolization.
Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
[TBL] [Abstract][Full Text] [Related]
5. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
[TBL] [Abstract][Full Text] [Related]
6. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
8. Quantitative comparison of pre-therapy
Knešaurek K; Tuli A; Pasik SD; Heiba S; Kostakoglu L
Eur J Radiol; 2018 Dec; 109():57-61. PubMed ID: 30527312
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
10. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.
Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA
Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
Garin E; Lenoir L; Rolland Y; Edeline J; Mesbah H; Laffont S; Porée P; Clément B; Raoul JL; Boucher E
J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.
Bilbao JI; Garrastachu P; Herráiz MJ; Rodríguez M; Iñarrairaegui M; Rodríguez J; Hernández C; de la Cuesta AM; Arbizu J; Sangro B
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):523-31. PubMed ID: 19841973
[TBL] [Abstract][Full Text] [Related]
13. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
[TBL] [Abstract][Full Text] [Related]
14. Comparison of perfused volume segmentation between cone-beam CT and
Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
[TBL] [Abstract][Full Text] [Related]
15. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization.
Louie JD; Kothary N; Kuo WT; Hwang GL; Hofmann LV; Goris ML; Iagaru AH; Sze DY
J Vasc Interv Radiol; 2009 May; 20(5):606-13. PubMed ID: 19345589
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of repeat angiographic assessment in patients designated for radioembolization using yttrium-90 microspheres with initial extrahepatic accumulation of technitium-99m macroaggregated albumin: a single center's experience.
Dudeck O; Wilhelmsen S; Ulrich G; Löwenthal D; Pech M; Amthauer H; Ricke J
Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1083-93. PubMed ID: 21833803
[TBL] [Abstract][Full Text] [Related]
17. Invited Commentary: (90)Y Radioembolization.
Kalva SP; Sutphin PD
Radiographics; 2015; 35(5):1618-20. PubMed ID: 26230756
[No Abstract] [Full Text] [Related]
18. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization?
Burgmans MC; Too CW; Kao YH; Goh AS; Chow PK; Tan BS; Tay KH; Lo RH
Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG
J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
[TBL] [Abstract][Full Text] [Related]
20. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
